VistaGen Therapeutics(VTGN) - 2023 Q3 - Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2023 Earnings Conference Call February 7, 2023 5:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Executive Officer Jerrold Dotson - Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies LLC Timothy Lugo - William Blair & Company LLC Operator Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-on ...